Stallion India Fluorochemicals Limited, a player in the processing and sale of refrigerant and industrial gases, is preparing for its market debut with an initial public offering (IPO) valued at ₹199.45 crores. The offering, which includes a fresh issue of 1.79 crore shares worth ₹160.73 crores and an offer for sale of 0.43 crore shares valued at ₹38.72 crores, is set to open from January 16 to January 20, 2025. With a price band of ₹85 to ₹90 per share and a lot size of 165 shares, the IPO offers an appealing entry point for investors looking to tap into the growing fluorochemicals market.
This is an exciting opportunity for retail investors to participate with a minimum investment of ₹14,850. The share allotment process will be completed by January 21, 2025, with a listing on both the Bombay Stock Exchange (BSE) and National Stock Exchange (NSE) scheduled for January 23, 2025. Don’t miss out on the chance to be part of a promising company poised for future growth in the fluorochemicals sector. Take action today and explore the potential this IPO offers!
Stallion India Fluorochemicals Limited IPO is a fundraise worth ₹199.45 crores comprising fresh issue of 1.79 crore shares and offer for sale of 0.43 crore shares. The IPO will be available for subscription from January 16, 2025, to January 20, 2025, providing an opportunity for investors looking to gain a stake in the fluorochemicals sector.
| Stallion India Fluorochemicals IPO date | January 16, 2025 - January 20, 2025 |
| Price band | ₹85 to ₹90 per share |
| Face value | ₹10 per share |
| Lot size | 165 shares |
| Issue type | Book-built issue IPO |
| Fresh issue | 1,78,58,740 shares amounting to ₹160.73 crores |
| Offer for Sale (OFS) | 43,02,656 shares amounting to ₹38.72 crores |
| Total issue size | 2,21,61,396 shares amounting to ₹199.45 crores |
| Listing at | BSE, NSE |
| Share holding post issue | 7,93,25,254 shares |
| Share holding pre issue | 6,14,66,514 shares |
The Stallion India Fluorochemicals Limited IPO opens for subscription on MONTH DATE, 2025, and closes on MONTH DATE, 2025, with allotment slated for December 24, 2024.
| IPO open date | January 16, 2025 (Thursday) |
| IPO close date | January 20, 2025 (Monday) |
| Basis of allotment | January 21, 2025 (Tuesday) |
| Initiation of refunds | January 22, 2025 (Wednesday) |
| Credit of shares to demat account | January 22, 2025 (Wednesday) |
| Listing date on exchanges | January 23, 2025 (Thursday) |
| Cut-off time for UPI mandate confirmation | 5 PM on January 20, 2025 (Monday) |
Stallion India Fluorochemicals Limited, established in 2002, has emerged as a significant player in the refrigerant and industrial gases sector, specializing in debulking, blending, and processing these gases, along with the distribution of pre-filled cans and small cylinders/containers. The company operates through a strategic network of four manufacturing plants located across Maharashtra, Rajasthan, and Haryana, ensuring efficient production and distribution capabilities across India.
With a focus on fluorochemicals, primarily used as refrigerants, Stallion has diversified its market presence across multiple industries. Their products serve critical roles in various sectors including semiconductor manufacturing, automotive, electronics, pharmaceuticals, healthcare, and specialized applications such as fire extinguishers, spray foam, glass bottle manufacturing, and aerosol production, demonstrating the company's broad market reach and industrial significance.
The fresh issue proceeds will be strategically allocated across several key initiatives: supporting the company's incremental working capital needs, financing capital expenditure for their semiconductor and specialty gas facility in Khalapur, Maharashtra, funding the development of a refrigerant debulking and blending facility in Mambattu, Andhra Pradesh, and addressing general corporate requirements, collectively aimed at expanding the company's operational capabilities and market presence.
The Stallion India Fluorochemicals Limited IPO showcases a healthy market capitalization of ₹713.93 crores. Key performance indicators, as on March 31, 2024, reflect the company's financial health, with a Return on Equity (RoE) of 12.54%, Return on Capital Employed (RoCE) of 13.96%, and Debt-to-Equity ratio of 0.55.
The Return on Net Worth (RoNW) stands at 12.54%, while the Price-to-Book Value (P/BV) is seen at 4.69. The PAT Margin is 6.26%.A comparison of earnings per share (EPS) reveals a pre-IPO EPS of ₹2.41 while it is ₹4.18 post-IPO. Similarly, the price to earnings ratio (P/E) is 37.41 pre-IPO and 21.55 post IPO.
| Period Ended | September 30, 2024 | March 31, 2024 | March 31, 2023 | March 31, 2022 |
| Revenue | 141.53 | 236.23 | 226.06 | 186.34 |
| Assets | 235.69 | 203.14 | 126.18 | 98.01 |
| Net Worth | 134.53 | 117.96 | 70.7 | 60.94 |
| Profit After Tax | 16.57 | 14.79 | 9.75 | 21.11 |
| Total Borrowing | 81.05 | 65.35 | 18.27 | 1.97 |
Amount in ₹ crores
Stallion India Fluorochemicals Limited has established itself as a formidable player in the specialty gases industry with over two decades of expertise, particularly in HFC and HFO specialty gas blending and manufacturing. Their strong market recognition is complemented by a diversified product portfolio that serves multiple high-growth industries, enabling risk mitigation through market diversification. The company's strategic network of four state-of-the-art manufacturing facilities across key regions of India ensures efficient distribution and demonstrates their commitment to maintaining stringent safety standards.
The company benefits from experienced promoters and key managerial personnel who have steered the organization to maintain a consistent track record of financial performance. Their client-centric approach, backed by robust industry knowledge and engineering proficiency, allows them to provide tailored solutions that enhance client efficiency and sustainability. The combination of their established industry presence, loyal customer base, and well-developed distribution network positions them strongly in the fluorochemicals market.
One of the primary challenges facing Stallion India Fluorochemicals is their significant dependence on bulk imports, particularly from China, for raw materials. This dependency exposes them to multiple risks including price fluctuations, global supply chain disruptions, and potential trade restrictions. Additionally, their current production capacity limitations could potentially constrain growth opportunities during periods of surge in demand, making the success of their IPO-funded expansion plans crucial for future growth.
The company faces several operational challenges including high working capital requirements that could impact their financial stability and business operations if not managed effectively. The presence of outstanding legal proceedings against promoters and directors poses reputational and operational risks. Their heavy reliance on refrigerant gases in limited geographical areas makes them vulnerable to demand fluctuations, while the increasingly competitive fluorochemicals market, with both established players and new entrants, puts pressure on their market share and pricing power.
The Stallion India Fluorochemicals Limited IPO presents a unique opportunity for investors to enter the fluorochemicals sector at an early stage. While the potential for growth is attractive, it's essential for investors to carefully assess the company's fundamentals, market position, and growth prospects. A well-informed approach, involving thorough research, will help ensure that this investment aligns with personal financial goals and risk appetite, turning a promising opportunity into a strategic financial move.
What is the Stallion India Fluorochemicals IPO?
The Stallion India Fluorochemicals Limited IPO is a main-board offering consisting of a fresh issue of 1.79 crore equity shares and an offer for sale of 0.43 crore shares with a face value of ₹10 per share, aiming to raise a total of ₹199.45 crores. The share price is set between ₹85 and ₹90, with a minimum order quantity of 165 shares. This IPO will be open for subscription from January 16, 2025, to January 20, 2025. Bigshare Services Private Limited is the registrar while Sarthi Capital Advisors Private Limited is the book-running lead manager.
When will the Stallion India Fluorochemicals IPO open?
The Stallion India Fluorochemicals Limited IPO will open for subscription on January 16, 2025, and will close on January 20, 2025.
When is the Stallion India Fluorochemicals IPO listing date?
The tentative listing date for the Stallion India Fluorochemicals Limited IPO is Thursday, January 23, 2025.
For android only